Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/25/1999 | US5906939 Cultured fibroblast or epithelial cell dissociation method using sulfated polysaccharide and chelator |
05/25/1999 | US5906938 Method of reconstituting hematopoietic cells using monoclonal antibodies to the stem cell factor receptor |
05/25/1999 | US5906936 Endowing lymphocytes with antibody specificity |
05/25/1999 | US5906935 Cells transformed or transfected with HCMV US2-US5, US10-US11 genes |
05/25/1999 | US5906930 Nucleic acid coding for mutant enzyme; for removal of carboxy acid protecting groups during synthesis of antibiotics like loracarbef |
05/25/1999 | US5906929 Enhanced inoculant for soybean cultivation |
05/25/1999 | US5906928 Efficient gene transfer into primary murine lymphocytes obviating the need for drug selection |
05/25/1999 | US5906925 Microorganisms and methods for overproduction of DAHP by cloned pps gene |
05/25/1999 | US5906923 ATPase inhibitor |
05/25/1999 | US5906922 Delivery of nucleic acids |
05/25/1999 | US5906920 Methods for the detection of ligands for retinoid X receptors |
05/25/1999 | US5906919 Method for chromosomes classification |
05/25/1999 | US5906917 Nucleic acid probes to mycobacterium tuberculosis |
05/25/1999 | US5906821 Viral nucleotide sequences |
05/25/1999 | US5906817 Biocompatible implant for the expression and in vivo secretion of a therapeutic substance |
05/25/1999 | US5906816 Method for treatment of autoimmune diseases |
05/25/1999 | CA2211702C Methods for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample |
05/25/1999 | CA1340563C Process for the multiple oxidation of steroids and genetically engineered cells to be used therefor |
05/25/1999 | CA1340557C Ckmb assay and monoclonal antibodies for use in same |
05/25/1999 | CA1340555C Oral vaccines |
05/21/1999 | CA2251257A1 Oncogene- or virus-controlled expression systems |
05/20/1999 | WO1999024836A1 125 human secreted proteins |
05/20/1999 | WO1999024621A2 Methods and compositions for detection of specific nucleotide sequences |
05/20/1999 | WO1999024617A1 Methods and compositions for peptide libraries displayed on light-emitting scaffolds |
05/20/1999 | WO1999024616A1 Method for identifying genes encoding signal sequences |
05/20/1999 | WO1999024615A2 Diagnostics and therapeutics for chronic obstructive airway disease |
05/20/1999 | WO1999024614A1 Diagnostic assay for cancer susceptibility |
05/20/1999 | WO1999024613A1 Human blood bacterium |
05/20/1999 | WO1999024612A2 Multiple sequential polynucleotide displacement reactions for signal amplification and processing |
05/20/1999 | WO1999024609A1 Gene analysis method |
05/20/1999 | WO1999024607A2 DETECTION AND TYPING OF THE iceA GENE OF $i(HELICOBACTER PYLORI) |
05/20/1999 | WO1999024606A2 Specific and sensitive nucleic acid detection method |
05/20/1999 | WO1999024605A2 Dna with promoter activity for cell cycle genes |
05/20/1999 | WO1999024603A1 Method for identifying drug targets |
05/20/1999 | WO1999024601A1 Secreted protein nsl4 |
05/20/1999 | WO1999024596A1 Expression plasmids for multiepitope nucleic acid-based vaccines |
05/20/1999 | WO1999024595A1 The translation enhancer element of the human amyloid precursor protein gene |
05/20/1999 | WO1999024594A1 Gene coding for thanatin, vector containing same and resulting transformed disease-resistant plants |
05/20/1999 | WO1999024593A1 Nucleic acid molecules which encode proteins having fructosyl transferase activity and methods for producing long-chain inulin |
05/20/1999 | WO1999024592A1 Protein production in transgenic alfalfa plants |
05/20/1999 | WO1999024591A1 Non rcr leuconostoc plasmid capable of being transferred into lactic acid bacteria; use as cloning and expressing tool |
05/20/1999 | WO1999024590A1 Suicide expression vector for vaccine strains |
05/20/1999 | WO1999024589A2 Lysozym-analogous proteins and peptide having an anti-microbial activity, production of the same and use thereof |
05/20/1999 | WO1999024588A1 cDNA CLONE OF ENDO-β-MANNANASE FROM PLANT TISSUES |
05/20/1999 | WO1999024587A2 Human phospholipase a2 protein and dna encoding it |
05/20/1999 | WO1999024586A1 Chimeric hydroxy-phenyl pyruvate dioxygenase, dna sequence and method for obtaining plants containing such a gene, with herbicide tolerance |
05/20/1999 | WO1999024585A1 Mutated hydroxy-phenyl pyruvate dioxygenase, dna sequence and method for obtaining herbicide-tolerant plants containing such gene |
05/20/1999 | WO1999024583A1 Dna demethylase, therapeutic and diagnostic uses thereof |
05/20/1999 | WO1999024582A1 Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor |
05/20/1999 | WO1999024581A2 Plant-optimized genes encoding pesticidal toxins |
05/20/1999 | WO1999024580A2 Essential fungal genes and their use |
05/20/1999 | WO1999024579A1 Novel era |
05/20/1999 | WO1999024578A2 Neisserial antigens |
05/20/1999 | WO1999024577A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS) |
05/20/1999 | WO1999024576A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |
05/20/1999 | WO1999024575A1 dull1 CODING FOR A STARCH SYNTHASE AND USES THEREOF |
05/20/1999 | WO1999024574A2 Plant homologs of yeast pad1, yeast crm1, and human jab1: regulators of ap-1 type transcription factor activity |
05/20/1999 | WO1999024573A2 SOYBEAN HOMOLOG OF SEED-SPECIFIC TRANSCRIPTION ACTIVATOR FROM $i(PHASEOLUS VULGARIS) |
05/20/1999 | WO1999024572A1 Genes with restricted expression in mesencephalic dopaminergic neurons |
05/20/1999 | WO1999024571A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis |
05/20/1999 | WO1999024570A1 Ciita-interacting proteins and methods of use therefor |
05/20/1999 | WO1999024569A1 Human lysophosphatidic acid receptor and use thereof |
05/20/1999 | WO1999024568A1 Steroid hormone binding protein |
05/20/1999 | WO1999024567A1 Tissue cement proteins from rhipicephalus appendiculatus |
05/20/1999 | WO1999024566A1 Tumor-specific antigens, methods for their production and their use for immunization and diagnosis |
05/20/1999 | WO1999024565A1 Methods and compositions for immunomodulation |
05/20/1999 | WO1999024564A1 PRODUCTION OF NOVEL BOVINE RESPIRATORY SYNCYTIAL VIRUSES FROM cDNAs |
05/20/1999 | WO1999024563A1 Surrogate genetics target characterization method |
05/20/1999 | WO1999024562A1 Method of increasing efficiency of directed evolution of a gene using phagemid |
05/20/1999 | WO1999024561A2 Genetic engineering of lignin biosynthesis in plants |
05/20/1999 | WO1999024560A1 Compositions and methods for inhibiting the activity of certain genes |
05/20/1999 | WO1999024559A2 Nuclear targeting by means of streptococcal protein h |
05/20/1999 | WO1999024554A2 Isolation, characterization, and identification of dendritic like cells and methods of using same |
05/20/1999 | WO1999024473A1 Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
05/20/1999 | WO1999024472A2 Glycosylated antibodies and antibody fragments having reactive ketone groups |
05/20/1999 | WO1999024471A1 Opiate, cannabinoid, and estrogen receptors |
05/20/1999 | WO1999024470A1 Mammalian milk growth factor |
05/20/1999 | WO1999024469A1 Secreted proteins and polynucleotides encoding them |
05/20/1999 | WO1999024466A2 Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes |
05/20/1999 | WO1999024463A2 Signal peptide-containing proteins |
05/20/1999 | WO1999024457A1 Dna regulatory element for the expression of transgenes in neurons of the mouse forebrain |
05/20/1999 | WO1999024455A1 Detection systems for registering protein interactions and functional relationships |
05/20/1999 | WO1999024453A1 Mammalian pro-apoptotic bok genes and their uses |
05/20/1999 | WO1999024411A1 Receptor with an affinity for compounds of the oxazoline class |
05/20/1999 | WO1999024058A2 Neuronal uses of bmp-11 |
05/20/1999 | WO1999024057A2 Neuronal uses of bmp-11 |
05/20/1999 | WO1999024052A2 Use of protein h as cytostatic agent |
05/20/1999 | WO1999024050A1 High throughput method for functionally classifying proteins identified using a genomics approach |
05/20/1999 | WO1999023879A1 Method for the augmentation of gene expression |
05/20/1999 | WO1999023867A2 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
05/20/1999 | WO1999018228A3 Method for microbial production of amino acids of the aspartate and/or glutamate family and agents which can be used in said method |
05/20/1999 | WO1999018213A8 MUTANTS OF YEAST Cdc24p, DEFECTIVE IN BINDING OF THE G-PROTEIN BETA SUBUNIT |
05/20/1999 | WO1999016890A3 Production of proteins in plant seeds |
05/20/1999 | WO1999016880A3 Protein involved in abscisic acid signalling |
05/20/1999 | WO1999016871A3 Nucleic acid catalysts with endonuclease activity |
05/20/1999 | WO1999016782A3 Regulation of gene expression |
05/20/1999 | WO1999015674A3 Transgenic plants having early-ripening and completely withering aerial parts |
05/20/1999 | WO1999015665A3 Mutants of thyroid stimulating hormone and methods based thereon |
05/20/1999 | WO1999015653A3 Tie ligand homologues |
05/20/1999 | WO1999015649A3 Composition and method for enhancing paracellular transport across cell layers |